Charing Cross Hospital

SepTiC Trial Investigates Enhanced Treatment Strategies for Sepsis Patients

8 months ago

• The SepTiC study aims to refine sepsis treatment by addressing key questions regarding rapid testing, fluid management, and immune system support. • Rapid PCR testing is being used to identify infections quickly, potentially reducing the use of broad-spectrum antibiotics and combating antimicrobial resistance. • The trial is evaluating whether reducing excess fluid in patients whose condition is improving can aid organ recovery and improve outcomes. • Researchers are also assessing if the immune-stimulating medication GM-CSF (Sargramostim) can lower the risk of subsequent infections and enhance recovery in sepsis patients.